GlaxoSmithKline Plc (GSK)

41.25
0.01 0.02
NYSE : Health Technology
Prev Close 41.24
Open 41.45
Day Low/High 41.25 / 41.62
52 Wk Low/High 35.77 / 42.36
Volume 2.51M
Avg Volume 2.94M
Exchange NYSE
Shares Outstanding 2.48B
Market Cap 101.67B
EPS 2.00
P/E Ratio 23.70
Div & Yield 2.06 (5.05%)

3 'Wide Moat' Stocks That Could Float Your Boat

This trio enjoys competitive advantages that should serve investors well over the long haul.

Don't Short the Gap, Go Long (Plus: GSK, WHR, AA)

Use $24 or $26 as a stop point. 

GlaxoSmithKline Sets Up for a Rally; Shares Could Rise 25%

The stock has put in a tradable low that can support a respectable rally that could carry into early 2016.

What to Watch Wednesday: Walgreens Boots Alliance Takes the Spotlight

What to Watch Wednesday: Walgreens Boots Alliance Takes the Spotlight

For Wednesday October 28, TheStreet awaits quarterly results from Walgreens Boots Alliance (WBA), Mondelez (MDLZ), Fiat Chrysler (FCAU), Amgen (AMGN), PayPal (PYPL), Buffalo Wild Wings (BWLD) and more.

A Small Pharma Stock With Big Potential

A Small Pharma Stock With Big Potential

Pernix looks poised for a strong 2016.

Is the Worst Over for GlaxoSmithKline?

The charts show that the stock is due for a rally.

Eli Lilly Shares Are Full of Life With 30% Upside

Eli Lilly has bucked the downtrend in other pharma names, and its chart is pointed higher.

Don't Miss These 3 Biotech Stocks

Don't Miss These 3 Biotech Stocks

Investors have been distracted by the Fed, and that's a shame.

U.S. Stocks Open Higher Following Japan's Biggest Stock Surge in 7 Years

U.S. Stocks Open Higher Following Japan's Biggest Stock Surge in 7 Years

U.S. stocks open sharply higher Wednesday. Wall Street followed a 7.7 percent gain in Japan's Nikkei Stock Index, the biggest percentage gain since October 2008.

What Stocks Are Value Investors Buying?

Not many, according to filings from Tweedy Browne and Kahn Brothers.

What Are Portfolio Managers Afraid Of?

They should learn to trust techs, financials.

Obamacare Ruling Means the Debate Is Over

As health-care stocks rally, it's time for politicians to move on.

Put Health Care Stocks on Shopping List

Put Health Care Stocks on Shopping List

Have it ready in case market turns volatile.

Health Care Mergers Are Just Getting Started

Deals coming fast and furious in the best group in town.

Portfolio Managers Shop for Growth

Combined Heinz-Kraft heads a long second-quarter list.

Agenus: A Promising Biotech Play

Agenus: A Promising Biotech Play

Approval of malaria vaccine could provide a shot in the arm.

Merger Mania Benefits Mylan

Merger Mania Benefits Mylan

Whether it's acquiring or the acquired, Mylan is building shareholder value.

Profit From the Longer Life Spans, Part 1

Profit From the Longer Life Spans, Part 1

Americans are living much longer these days -- and there are a number of ways to invest.

What to Watch on Wall Street for Wednesday, October 22nd 2014

What to Watch on Wall Street for Wednesday, October 22nd 2014

On Wednesday, October 22nd we continue a busy earnings week, with the country's second largest wireless carrier, AT&T Inc.

A Memo to the Activists

Stop picking on PepsiCo, Allergan and Apple.

What You Need to Know About Female Whistleblowers in the Workplace

What You Need to Know About Female Whistleblowers in the Workplace

Federal Reserve Bank of New York, Goldman Sachs, secretly recorded tapes, and a female employee fired -- those are all real life elements from the headlines circulating around Carmen Segarra.

Five Things to Know Now: Relief Rally

European stocks reach highest level since Jan. 2008.

Five Things to Know Now

European stocks pull back on new worries about Ukraine.

Two Giants Blindsided by Major Trends

McDonald's and GlaxoSmithKline are fighting against major turns of the tide.

London Calling

Your portfolio could use an English touch.

What to Watch Monday, May 5: Earnings From Drug Giant Pfizer

What to Watch Monday, May 5: Earnings From Drug Giant Pfizer

Investors will be tracking Pfizer's earnings when they report first-quarter results on May 5. Expectations are for earnings of $0.55 a share on sales of $12.07 billion.

GlaxoSmithKline upgraded at Argus

Day Ahead: Awash in Earnings

Futures point higher; blockbuster drug deal boosts European markets.

The Cloud Is the Prescription

The Cloud Is the Prescription

Medidata Solutions is focusing its cloud-computing offerings on the pharmaceutical industry.

The Turning Point for Defensives?

The untold story about these stocks is how they have held up.